Who has invested in Aeglea BioTherapeutics?

Fairmount Funds are named among the investors backing Aeglea BioTherapeutics.

Aeglea BioTherapeutics Funding: $375M Raised, Growth (2023)

Aeglea BioTherapeutics funding overview

Aeglea BioTherapeutics is based in Austin, Texas. Aeglea BioTherapeutics has raised $375M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in November 2023. The round record for Aeglea BioTherapeutics runs through 2023; nothing later has been disclosed. Investors on record include Fairmount Funds.

Aeglea BioTherapeutics at a glance

Total raised: $375M
Latest round: Growth
Latest round date: November 2023
Headquarters: Austin, Texas
Notable investors: Fairmount Funds

Frequently asked about Aeglea BioTherapeutics funding

How much has Aeglea BioTherapeutics raised?: Aeglea BioTherapeutics has raised $375M in total disclosed funding across the rounds on record.
Who has invested in Aeglea BioTherapeutics?: Fairmount Funds are named among the investors backing Aeglea BioTherapeutics.
What was the latest Aeglea BioTherapeutics funding round?: The most recent disclosed round is a Growth, announced in November 2023.
Where is Aeglea BioTherapeutics based?: Aeglea BioTherapeutics is based in Austin, Texas.
When did Aeglea BioTherapeutics last raise?: The last disclosed Aeglea BioTherapeutics round closed in November 2023 at Growth.

Round data for Aeglea BioTherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Austin and backer lists below.

Aeglea BioTherapeutics Funding: $375M Raised, Growth (2023)

Aeglea BioTherapeutics funding overview

Aeglea BioTherapeutics at a glance

Frequently asked about Aeglea BioTherapeutics funding

Companies related to Aeglea BioTherapeutics (20)

Browse related funding lists (5)